Discover the X Factor in Wound Care
Next Science’s flagship product, BlastX™ is an antimicrobial wound gel powered by a patented, non-toxic technology that physically disrupts the biofilm matrix. As a result, bacteria within the gel are exposed and more vulnerable to attack by antimicrobials, antibiotics, and the body’s natural immune defenses.
BlastX is indicated for the management of wounds such as Stage I-IV pressure ulcers, partial- and full-thickness wounds, diabetic foot and leg ulcers, post-surgical wounds, first and second degree burns, and grafted and donor sites.
BlastX is non-toxic and compatible with a broad range of advanced healing modalities that set the stage for better preparation and ongoing care of the wound bed.
BlastX works by physically dismantling the extracellular polymeric substance (EPS) matrix, which is the main component of biofilm. By destroying the EPS matrix, BlastX also prevents the growth of further biofilm within the gel.
BlastX™ Supersedes Current Therapy By Reducing Bacteria 7-8 Log
In in vitro studies, BlastX was compared to SilvaSorb® Wound Gel and Microcyn® Wound Gel. 24 hours after application, measurements were taken for two different kinds of bacteria (S. aureus and P. aeruginosa). Compared to the other two wound gels, BlastX significantly reduced the number of bacteria present by 7 to 8 log.24
BlastX™ Yields Seven-log Reduction of Bacteria
After 24 hours of in vitro growth, two species of bacterial biofilm were treated with BlastX, PuraPlyTM, gauze, or maintained as a control. The application of BlastX reduced the presence P. aeruginosa nearly seven-log.11
Healthcare Provider Resources
For medical professionals working in the field of wound care or burn treatment, learn more about how Next Science BlastX can help your practice and your patients.